Oneness Biotech Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 35.43%

Oneness Biotech Co Ltd (4743) has an Asset Resilience Ratio of 35.43% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 4743 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

NT$4.19 Billion

≈ $132.13 Million USD Cash + Short-term Investments

Total Assets

NT$11.84 Billion

≈ $372.98 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2024)

This chart shows how Oneness Biotech Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Oneness Biotech Co Ltd asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Oneness Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Oneness Biotech Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$4.19 Billion	35.43%
Total Liquid Assets	NT$4.19 Billion	35.43%

Asset Resilience Insights

Very High Liquidity: Oneness Biotech Co Ltd maintains exceptional liquid asset reserves at 35.43% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Oneness Biotech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Oneness Biotech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	72.23%
Abivax SA PA:ABVX	Biotechnology	2.34%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Oneness Biotech Co Ltd (2009–2024)

The table below shows the annual Asset Resilience Ratio data for Oneness Biotech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	43.71%	NT$5.97 Billion ≈ $188.13 Million	NT$13.66 Billion ≈ $430.35 Million	-1.59pp
2023-12-31	45.30%	NT$6.96 Billion ≈ $219.28 Million	NT$15.36 Billion ≈ $484.04 Million	+29.95pp
2022-12-31	15.35%	NT$2.39 Billion ≈ $75.35 Million	NT$15.58 Billion ≈ $490.87 Million	-32.15pp
2021-12-31	47.50%	NT$7.47 Billion ≈ $235.44 Million	NT$15.73 Billion ≈ $495.61 Million	-5.14pp
2020-12-31	52.65%	NT$8.10 Billion ≈ $255.17 Million	NT$15.38 Billion ≈ $484.69 Million	+32.28pp
2019-12-31	20.37%	NT$1.42 Billion ≈ $44.79 Million	NT$6.98 Billion ≈ $219.90 Million	-0.11pp
2018-12-31	20.48%	NT$478.25 Million ≈ $15.07 Million	NT$2.34 Billion ≈ $73.58 Million	-15.19pp
2017-12-31	35.67%	NT$899.36 Million ≈ $28.33 Million	NT$2.52 Billion ≈ $79.44 Million	-15.55pp
2016-12-31	51.22%	NT$1.31 Billion ≈ $41.24 Million	NT$2.56 Billion ≈ $80.52 Million	+12.26pp
2015-12-31	38.95%	NT$1.09 Billion ≈ $34.45 Million	NT$2.81 Billion ≈ $88.45 Million	-18.75pp
2014-12-31	57.71%	NT$1.16 Billion ≈ $36.62 Million	NT$2.01 Billion ≈ $63.46 Million	+7.32pp
2013-12-31	50.39%	NT$1.05 Billion ≈ $33.18 Million	NT$2.09 Billion ≈ $65.84 Million	+27.30pp
2012-12-31	23.09%	NT$329.27 Million ≈ $10.37 Million	NT$1.43 Billion ≈ $44.93 Million	+11.10pp
2011-12-31	11.99%	NT$166.31 Million ≈ $5.24 Million	NT$1.39 Billion ≈ $43.71 Million	+0.33pp
2009-12-31	11.66%	NT$129.76 Million ≈ $4.09 Million	NT$1.11 Billion ≈ $35.07 Million	--

pp = percentage points

About Oneness Biotech Co Ltd

TWO:4743 Taiwan Biotechnology

Market Cap

$687.33 Million

NT$21.82 Billion TWD

Market Cap Rank

#10813 Global

#371 in Taiwan

Share Price

NT$45.60

Change (1 day)

+2.13%

52-Week Range

NT$41.15 - NT$76.70

All Time High

NT$395.32